A way to vaccinate newborn babies safely and reduce infant mortality may have been discovered by immunologists in the US. A study at the Children's Hospital in Boston found a molecule, called Toll-like receptor 8, which could be used to stimulate the immune system of newborns to enable vaccination. At present, most immunisations are not given to babies under 2 months old.
At present, most immunisations are not given to babies under 2 months old.
The hospital team say these earlier vaccinations could reduce infant mortality.
Register now to continue reading
Thank you for visiting Nursery World and making use of our archive of more than 35,000 expert features, subject guides, case studies and policy updates. Why not register today and enjoy the following great benefits:
What's included
-
Free access to 4 subscriber-only articles per month
-
Unlimited access to news and opinion
-
Email newsletter providing activity ideas, best practice and breaking news
Already have an account? Sign in here
